The Latest Breaking News from Pfizer

Since the uncertain economic conditions are expected to keep the stock market under pressure, dividend-paying stocks Pfizer (PFE), ICL Group (ICL), and ARC Document Solutions (ARC) could be solid additions to your portfolio for generating a steady income stream. Keep reading….

Though the U.S. economy bounced back after shrinking in the first half of the year, falling consumer spending and the rate hikes to tame high inflation might lead the economy into a recession. Hence, investors looking for passive income could invest in fundamentally sound dividend-paying stocks Pfizer (PFE), Sanofi (SNY),…

Wall Street Journal Tesla’s Autopilot Draws Regulatory Ire From DoJ and SEC

China's largest city of Shanghai is ordering mass testing on all 1.3 million residents of its downtown Yangpu district and confining them to their homes at least until results are known

Benzinga

The Instagram headline was pithy and alarming: “Head of Pfizer Research: Covid Vaccine is Female Sterilization.” And the report, from a murky source, could have had real-world consequences, coming in 2020, just as the U.S. rolled out the first vaccines to combat the coronavirus pandemic.

A surge in cases of a common respiratory virus is filling up pediatric hospital beds around the U.S. The early and swift arrival of respiratory syncytial virus, or RSV, is stretching the limits of an already exhausted health care system. Layer on COVID and the flu, and you’ve got the…

Someone with a lot of money to spend has taken a bullish stance on Pfizer (NYSE:PFE). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Poor uptake in this age group is now likely to significantly add to the stress expected in the health sector over the coming winter months as services struggle to cope with a ‘twindemic’ of flu and Covid

A whale with a lot of money to spend has taken a noticeably bearish stance on Pfizer. Looking at options history for Pfizer (NYSE:PFE) we detected 20 strange trades.

Pfizer insists most Americans will still be able to access free vaccines, but public health advocates accuse it of “shameless” profiteering